{
    "data": [
        {
            "id": "69a1c12324c37e0001bc12aa",
            "title": "Why Is JinkoSolar Stock Falling Friday?",
            "description": "<div><div class=\"sc-gfrmXj kPLDLR\"><!--$--><p class=\"block core-block\"><strong>JinkoSolar Holding Co., Ltd. </strong><a href=\"https://www.benzinga.com/quote/JKS\" rel=\"noreferrer noopener\" target=\"_blank\"></a><a class=\"ticker-link\" data-exchange=\"NYSE\" data-ticker=\"JKS\" href=\"https://www.benzinga.com/quote/JKS\" rel=\"noopener\" target=\"_blank\">(NYSE:</a><a class=\"ticker\" href=\"https://www.benzinga.com/quote/JKS\" target=\"_blank\">JKS</a>)<!-- --> shares plunged Friday after the company unveiled weak <a href=\"https://www.benzinga.com/pressreleases/26/02/n50924434/jinkosolars-subsidiary-jinko-solar-co-ltd-announces-certain-preliminary-unaudited-financial-result\" rel=\"noreferrer noopener\" target=\"_blank\">preliminary 2025 results</a> for its majority-owned subsidiary,<strong> Jiangxi Jinko</strong>, flagging a sharp drop in revenue and a substantial net loss for the full year.</p><!--/$--><!--$--><h2 class=\"wp-block-heading\">2025 Preliminary Results Impact JKS Stock</h2><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><p class=\"block core-block\">JinkoSolar has released preliminary unaudited financial results for its majority-owned subsidiary, Jiangxi Jinko, revealing a steep deterioration in performance for the full year ended December 31, 2025.</p><!--/$--><!--$--><p class=\"block core-block\">Jiangxi Jinko recorded total revenues of 65.49 billion yuan (~$9.57 billion), marking a sharp 29.18% year-on-year decline from 92.47 billion yuan in 2024. The subsidiary swung to a net loss of 6.79 billion yuan, compared to a net profit of 98.9 million yuan in the prior year — a staggering 6,959.50% reversal. Excluding non-recurring gains and losses, the net loss widened further to 7.64 billion yuan.</p><!--/$--><!--$--><p class=\"block core-block\">Falling prices for photovoltaic products drove the deterioration, pushing operating losses to 9.11 billion yuan, compared with an operating profit of 792.96 million yuan in 2024.</p><!--/$--><!--$--><div class=\"sc-jHrKIi gTZsSs\"></div><!--/$--><!--$--><p class=\"block core-block\">Total equity attributable to the parent company also contracted by 21.19%, dropping from 32.31 billion yuan to 25.46 billion yuan.</p><!--/$--><!--$--><p class=\"block core-block\">JinkoSolar, which holds approximately 55.59% equity interest in Jiangxi Jinko, cautioned investors that these results remain unaudited, are subject to change, and differ from its consolidated financials prepared under U.S. GAAP.</p><!--/$--><!--$--><h2 class=\"wp-block-heading\">JKS Faces Bearish Sentiment</h2><!--/$--><!--$--><p class=\"block core-block\">JinkoSolar’s stock is currently trading below several key moving averages, which typically signals bearish sentiment among investors. The shares are 6.4% below the 20-day SMA, 7.7% below the 50-day SMA, and 3.9% below the 100-day SMA, yet they remain 4.2% above the 200-day SMA. This mixed positioning suggests a lack of clear directional momentum in the near term.</p><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><h2 class=\"wp-block-heading\">Upcoming Earnings</h2><!--/$--><!--$--><p class=\"block core-block\">JinkoSolar Holding Co. will release its next financial update on March 25, 2026.</p><!--/$--><!--$--><ul class=\"wp-block-list\">\n<li><strong>EPS Estimate</strong>: Loss of 62 cents (Up from a loss of $1.02 YoY)</li>\n<li><strong>Revenue Estimate</strong>: $2.79 billion (Down from $2.83 billion YoY)</li>\n</ul><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><p class=\"block core-block\"><strong>Analyst Consensus &amp; Recent Actions:</strong> The stock carries a Hold Rating with an average price target of $28.62. Recent analyst moves include:</p><!--/$--><!--$--><ul class=\"wp-block-list\">\n<li><strong>Roth Capital</strong>: Neutral (Raises Target to $25.00) (Nov. 21, 2025)</li>\n<li><strong>Goldman Sachs</strong>: Sell (Raises Target to $20.00) (Nov. 19, 2025)</li>\n<li><strong>Goldman Sachs</strong>: Sell (Raises Target to $18.00) (Oct. 8, 2025)</li>\n</ul><!--/$--><!--$--><h2 class=\"wp-block-heading\"> Benzinga Edge Scorecard</h2><!--/$--><!--$--><p class=\"block core-block\">Below is the <a href=\"https://www.benzinga.com/screener\" rel=\"noreferrer noopener\" target=\"_blank\">Benzinga Edge scorecard</a> for the company, highlighting its strengths and weaknesses compared to the broader market:</p><!--/$--><!--$--><ul class=\"wp-block-list\">\n<li><strong>Momentum</strong>: Neutral (Score: 64.67) — The stock shows moderate momentum in the market.</li>\n</ul><!--/$--><!--$--><div class=\"nativo-placement-in-content-ap\"></div><!--/$--><!--$--><p class=\"block core-block\"><strong>The Verdict:</strong> JinkoSolar’s Benzinga Edge signals neutral market performance, with a moderate Momentum score of 64.67 — neither significantly outperforming nor lagging its peers.</p><!--/$--><!--$--><p class=\"block core-block\"><strong>JKS Price Action:</strong> JinkoSolar Holding Co shares were down 4.38% at $25.30 at the time of publication on Friday, <a href=\"https://www.benzinga.com/pro/\" rel=\"noreferrer noopener\" target=\"_blank\">according to Benzinga Pro data</a>.</p><!--/$--><!--$--><p class=\"block core-block\"><em>Photo by Robert Way via Shutterstock</em></p><!--/$--><!--$--><div class=\"bz-optimizely-campaign bz-optimizely-campaign-bottom-50933426\" data-nosnippet=\"true\"></div><!--/$--></div></div>",
            "image": "https://www.benzinga.com/files/images/story/2026/02/27/Shanghai-china-november-20th-2022-Jinko-.jpeg",
            "link": "https://www.benzinga.com/trading-ideas/movers/26/02/50933426/why-is-jinkosolar-stock-falling-friday",
            "pub_date": "2026-02-28 00:07:02",
            "source": "benzinga",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "69a1c1c424c37e0001bc1371",
            "title": "CoreWeave Posts Q4 Revenue Beat, Guides To 140% Growth In 2026",
            "description": "<div><div class=\"sc-gfrmXj kPLDLR\"><!--$--><p class=\"block core-block\">Shares of<strong> CoreWeave Inc <a class=\"ticker-link\" data-exchange=\"NASDAQ\" data-ticker=\"CRWV\" href=\"https://www.benzinga.com/quote/CRWV\" rel=\"noopener\" target=\"_blank\">(NASDAQ:</a><a class=\"ticker\" href=\"https://www.benzinga.com/quote/CRWV\" target=\"_blank\">CRWV</a>)<!-- --> </strong>tanked in early trading on Friday, after the company reported <a href=\"https://www.benzinga.com/markets/earnings/26/02/50913508/coreweave-stock-slides-on-mixed-q4-earnings-despite-signaling-hypergrowth-ahead\" target=\"_blank\">mixed fourth-quarter results</a>.</p><!--/$--><!--$--><p class=\"block core-block\">Here are the key analyst insights:</p><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$?--><template id=\"B:2\"></template><div></div><!--/$--><!--$--><p class=\"block core-block\"><strong>Check out <a href=\"https://www.benzinga.com/analyst-stock-ratings\" target=\"_blank\">other analyst stock ratings</a></strong>.</p><!--/$--><!--$--><p class=\"block core-block\"><strong>DA Davidson: </strong>CoreWeave reported total revenue of $1.6 billion, representing 110% year-on-year growth, Platt said in a note. The company's revenue backlog grew to $66.8 billion, mainly due to an additional contract from <strong>Meta Platforms Inc </strong>(NASDAQ:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/META\" target=\"_blank\">META</a>) valued around $5 billon, he added.</p><!--/$--><!--$--><div class=\"sc-jHrKIi gTZsSs\"></div><!--/$--><!--$--><p class=\"block core-block\">CoreWeave reported strong earnings, driven by \"continued strong demand for AI compute,\" the analyst wrote. Management guided to full-year revenues of $12B-$13 billion, implying 140% growth at the midpoint, he further stated.</p><!--/$--><!--$--><p class=\"block core-block\"><strong>Cantor Fitzgerald: </strong>CoreWeave's backlogs grew more than 400% in the fourth quarter, up $11.2 billion sequentially and more than $50 billion year-on-year, Blakey said. The company exited 2025 with backlogs of $66.8 billion, providing strong visibility into the company's guidance for the second half of 2026 and 2027, he added.</p><!--/$--><!--$?--><template id=\"B:3\"></template><div></div><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><p class=\"block core-block\"><strong>Needham</strong><strong>: </strong>CoreWeave reported revenue of $1.57 billion, topping consensus of $1.55 billion, Cikos said. He added, however, that the company's operating profit of $88 million fell short of market expectations of $133 million.<strong></strong></p><!--/$--><!--$--><p class=\"block core-block\">Management projected capex to grow to $30-$35 billion, up more than 100% from $14.8 billion in 2025, the analyst stated. \"We remain Hold-rated as we expect CoreWeave to continue prioritizing CapEx spend, cutting into profitability, and muddying the evaluation of underlying unit economics,\" he further wrote.</p><!--/$--><!--$--><p class=\"block core-block\"><strong>CRWV Price Action:</strong> Shares of CoreWeave had declined by 17.9% to $80.04 at the time of publication on Friday.</p><!--/$--><!--$--><p class=\"block core-block\"><em>Image: Shutterstock</em></p><!--/$--><!--$--><div class=\"bz-optimizely-campaign bz-optimizely-campaign-bottom-50933596\" data-nosnippet=\"true\"></div><!--/$--></div></div>",
            "image": "https://www.benzinga.com/files/images/story/2026/02/27/Close-Up-Of-CoreWeave-Logo-And-Name-On-S.jpeg",
            "link": "https://www.benzinga.com/analyst-stock-ratings/price-target/26/02/50933596/coreweave-posts-q4-revenue-beat-guides-to-140-growth-in-2026",
            "pub_date": "2026-02-28 00:09:31",
            "source": "benzinga",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "69a1c01d24c37e0001bc1095",
            "title": "Preview: Ouster&#39;s Earnings",
            "description": "<div><div class=\"sc-gfrmXj kPLDLR\"><!--$--><p class=\"block core-block\">Ouster (NASDAQ:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/OUST\" target=\"_blank\">OUST</a>) is preparing to release its quarterly earnings on Monday, 2026-03-02. Here's a brief overview of what investors should keep in mind before the announcement.</p><!--/$--><!--$--><p class=\"block core-block\">Analysts expect Ouster to report an <strong>earnings per share</strong> (EPS) of $-0.24.</p><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><p class=\"block core-block\">The announcement from Ouster is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter.</p><!--/$--><!--$--><p class=\"block core-block\">It's worth noting for new investors that guidance can be a key determinant of stock price movements.</p><!--/$--><!--$--><h3 class=\"block core-block\">Performance in Previous Earnings</h3><!--/$--><!--$--><p class=\"block core-block\">In the previous earnings release, the company missed EPS by $0.09, leading to a 6.54% drop in the share price the following trading session.</p><!--/$--><!--$--><p class=\"block core-block\">Here's a look at Ouster's past performance and the resulting price change:</p><!--/$--><!--$--><div class=\"sc-jHrKIi gTZsSs\"></div><!--/$--><!--$?--><template id=\"B:2\"></template><div></div><!--/$--><!--$?--><template id=\"B:3\"></template><div></div><!--/$--><!--$--><h3 class=\"block core-block\">Ouster Share Price Analysis</h3><!--/$--><!--$--><p class=\"block core-block\">Shares of Ouster were trading at $19.63 as of February 26. Over the last 52-week period, shares are up 146.62%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. </p><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><h3 class=\"block core-block\">About Ouster</h3><!--/$--><!--$--><p class=\"block core-block\">Ouster Inc is a provider of lidar sensors for the automotive, industrial, robotics, and smart infrastructure industries. Ouster's products include high-resolution scanning and solid-state digital lidar sensors, Velodyne Lidar sensors, and software solutions. The company operates in the Americas, Asia and Pacific, Europe, Middle East, and Africa regions. It derives maximum revenue from Americas.</p><!--/$--><!--$--><h3 class=\"block core-block\">Understanding the Numbers: Ouster's Finances</h3><!--/$--><!--$--><p class=\"block core-block\"><strong>Market Capitalization Analysis:</strong> Reflecting a smaller scale, the company's market capitalization is positioned below industry averages. This could be attributed to factors such as growth expectations or operational capacity.</p><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><p class=\"block core-block\"><strong>Revenue Growth:</strong> Ouster displayed positive results in 3 months. As of 30 September, 2025, the company achieved a solid revenue growth rate of approximately <strong>40.78%</strong>. This indicates a notable increase in the company's top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Information Technology sector.</p><!--/$--><!--$--><p class=\"block core-block\"><strong>Net Margin:</strong> Ouster's net margin falls below industry averages, indicating challenges in achieving strong profitability. With a net margin of <strong>-54.99%,</strong> the company may face hurdles in effective cost management.</p><!--/$--><!--$--><p class=\"block core-block\"><strong>Return on Equity (ROE):</strong> Ouster's ROE is below industry averages, indicating potential challenges in efficiently utilizing equity capital. With an ROE of <strong>-9.28%,</strong> the company may face hurdles in achieving optimal financial returns.</p><!--/$--><!--$--><div class=\"nativo-placement-in-content-ap\"></div><!--/$--><!--$--><p class=\"block core-block\"><strong>Return on Assets (ROA):</strong> Ouster's ROA falls below industry averages, indicating challenges in efficiently utilizing assets. With an ROA of <strong>-6.43%,</strong> the company may face hurdles in generating optimal returns from its assets.</p><!--/$--><!--$--><p class=\"block core-block\"><strong>Debt Management:</strong> Ouster's debt-to-equity ratio is below the industry average at <strong>0.06</strong>, reflecting a lower dependency on debt financing and a more conservative financial approach.</p><!--/$--><!--$--><p class=\"block core-block\"><a href=\"https://www.benzinga.com/quote/OUST/earnings\" target=\"_blank\"><strong>To track all earnings releases for Ouster visit their earnings calendar on our site.</strong></a></p><!--/$--><!--$--><p class=\"block core-block\"><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p><!--/$--></div></div>",
            "image": "https://www.benzinga.com/files/images/story/2025/11/06/earnings_preview_4.jpg",
            "link": "https://www.benzinga.com/insights/earnings/26/02/50932988/preview-ousters-earnings",
            "pub_date": "2026-02-28 00:02:41",
            "source": "benzinga",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "69a1c02624c37e0001bc10a5",
            "title": "Earnings Outlook For Astrana Health",
            "description": "<div><div class=\"sc-gfrmXj kPLDLR\"><!--$--><p class=\"block core-block\">Astrana Health (NASDAQ:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/ASTH\" target=\"_blank\">ASTH</a>) will release its quarterly earnings report on Monday, 2026-03-02. Here's a brief overview for investors ahead of the announcement.</p><!--/$--><!--$--><p class=\"block core-block\">Analysts anticipate Astrana Health to report an <strong>earnings per share</strong> (EPS) of $0.26.</p><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><p class=\"block core-block\">The market awaits Astrana Health's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.</p><!--/$--><!--$--><p class=\"block core-block\">It's important for new investors to understand that guidance can be a significant driver of stock prices.</p><!--/$--><!--$--><h3 class=\"block core-block\">Overview of Past Earnings</h3><!--/$--><!--$--><p class=\"block core-block\">The company's EPS missed by $0.54 in the last quarter, leading to a 23.46% drop in the share price on the following day.</p><!--/$--><!--$--><p class=\"block core-block\">Here's a look at Astrana Health's past performance and the resulting price change:</p><!--/$--><!--$--><div class=\"sc-jHrKIi gTZsSs\"></div><!--/$--><!--$?--><template id=\"B:2\"></template><div></div><!--/$--><!--$?--><template id=\"B:3\"></template><div></div><!--/$--><!--$--><h3 class=\"block core-block\">Performance of Astrana Health Shares</h3><!--/$--><!--$--><p class=\"block core-block\">Shares of Astrana Health were trading at $20.91 as of February 26. Over the last 52-week period, shares are down 20.69%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release. </p><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><h3 class=\"block core-block\">All You Need to Know About Astrana Health</h3><!--/$--><!--$?--><template id=\"B:4\"></template><div></div><!--/$--><!--$--><h3 class=\"block core-block\">Astrana Health: Delving into Financials</h3><!--/$--><!--$--><p class=\"block core-block\"><strong>Market Capitalization Perspectives:</strong> The company's market capitalization falls below industry averages, signaling a relatively smaller size compared to peers. This positioning may be influenced by factors such as perceived growth potential or operational scale.</p><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><p class=\"block core-block\"><strong>Revenue Growth:</strong> Astrana Health's revenue growth over a period of 3 months has been noteworthy. As of 30 September, 2025, the company achieved a revenue growth rate of approximately <strong>99.71%</strong>. This indicates a substantial increase in the company's top-line earnings. When compared to others in the Health Care sector, the company excelled with a growth rate higher than the average among peers.</p><!--/$--><!--$--><p class=\"block core-block\"><strong>Net Margin:</strong> Astrana Health's net margin is below industry averages, indicating potential challenges in maintaining strong profitability. With a net margin of <strong>0.04%,</strong> the company may face hurdles in effective cost management.</p><!--/$--><!--$--><p class=\"block core-block\"><strong>Return on Equity (ROE):</strong> Astrana Health's ROE falls below industry averages, indicating challenges in efficiently using equity capital. With an ROE of <strong>0.05%,</strong> the company may face hurdles in generating optimal returns for shareholders.</p><!--/$--><!--$--><div class=\"nativo-placement-in-content-ap\"></div><!--/$--><!--$--><p class=\"block core-block\"><strong>Return on Assets (ROA):</strong> Astrana Health's ROA is below industry standards, pointing towards difficulties in efficiently utilizing assets. With an ROA of <strong>0.02%,</strong> the company may encounter challenges in delivering satisfactory returns from its assets.</p><!--/$--><!--$--><p class=\"block core-block\"><strong>Debt Management:</strong> With a high debt-to-equity ratio of <strong>1.4</strong>, Astrana Health faces challenges in effectively managing its debt levels, indicating potential financial strain.</p><!--/$--><!--$--><p class=\"block core-block\"><a href=\"https://www.benzinga.com/quote/ASTH/earnings\" target=\"_blank\"><strong>To track all earnings releases for Astrana Health visit their earnings calendar on our site.</strong></a></p><!--/$--><!--$--><p class=\"block core-block\"><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p><!--/$--></div></div>",
            "image": "https://www.benzinga.com/files/images/story/2025/11/06/earnings_preview_14.jpg",
            "link": "https://www.benzinga.com/insights/earnings/26/02/50932999/earnings-outlook-for-astrana-health",
            "pub_date": "2026-02-28 00:02:50",
            "source": "benzinga",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "69a1bea624c37e0001bc0f0d",
            "title": "Producer Inflation Jumps More Than Expected: Is The Fed&#39;s Rate-Cut Plan Now In Trouble?",
            "description": "<div><div class=\"sc-gfrmXj kPLDLR\"><!--$--><p class=\"block core-block\">The Producer Price Index delivered an upside surprise across the board in January, reviving concerns that price pressures remain sticky and complicating the <a href=\"https://www.benzinga.com/topic/federal-reserve\" target=\"_blank\">Federal Reserve's rate-cut timeline.</a></p><!--/$--><!--$--><p class=\"block core-block\">The Bureau of Labor Statistics reported Friday that headline producer prices rose 0.5% month over month in January, above the 0.3% consensus forecast and accelerating from December’s 0.4% pace. </p><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><p class=\"block core-block\">On a year-over-year basis, the PPI increased 2.9%, well above expectations of 2.6%, though slightly below December's 3.0%.</p><!--/$--><!--$--><p class=\"block core-block\">Core PPI, which excludes food and energy, jumped 0.8% in January — the highest print since July 2025 — sharply outpacing expectations of 0.3%.</p><!--/$--><!--$--><p class=\"block core-block\">On an annual basis, core producer prices rose 3.6%, again above the 3.0% forecast and up from 3.3% previously.</p><!--/$--><!--$--><div class=\"sc-jHrKIi gTZsSs\"></div><!--/$--><!--$--><h2 class=\"wp-block-heading\">Services Are The Problem</h2><!--/$--><!--$--><p class=\"block core-block\">The producer inflation impulse came from services. Final demand services surged 0.8% in January, the largest gain since July 2025.</p><!--/$--><!--$--><p class=\"block core-block\">More than 20% of that increase came from a 14.4% jump in margins for professional and commercial equipment wholesaling. </p><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><p class=\"block core-block\">Meanwhile, goods prices fell 0.3%, the biggest drop since March 2025. Energy prices declined 2.7%, led by a 5.5% drop in gasoline.</p><!--/$--><!--$--><p class=\"block core-block\">Nearly 80% of the decline in goods came from gasoline. </p><!--/$--><!--$--><p class=\"block core-block\">In other words, inflation cooled where it is volatile. It heated up where it tends to stick.</p><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><h2 class=\"wp-block-heading\">What It Means For The Fed</h2><!--/$--><!--$--><p class=\"block core-block\"><strong>Chris Zaccarelli</strong>, chief investment officer for Northlight Asset Management, said the report could rattle investors.</p><!--/$--><!--$--><p class=\"block core-block\">“This morning the PPI was higher than expected across the board and that could upset markets,\" Zaccarelli said.</p><!--/$--><!--$--><div class=\"nativo-placement-in-content-ap\"></div><!--/$--><!--$--><p class=\"block core-block\">Zaccarelli said that over the past month markets had focused heavily on AI disruption and its potential impact on the labor market, pushing inflation concerns into the background, but that the latest inflation readings could give the Fed another reason to remain patient on rate cuts and potentially wait until the second half of the year before making changes.</p><!--/$--><!--$--><p class=\"block core-block\">The expert also said the hotter inflation data adds another layer of concern within the traditional framework of price stability and full employment, even before accounting for AI's disruptive effects on the broader economy.</p><!--/$--><!--$--><h2 class=\"wp-block-heading\">Wall Street Heading For A Negative End To The Week</h2><!--/$--><!--$--><p class=\"block core-block\">The S&amp;P 500 — as tracked by the <strong>SPDR S&amp;P 500 ETF Trust</strong> <a class=\"ticker-link\" data-exchange=\"ARCA\" data-ticker=\"SPY\" href=\"https://www.benzinga.com/quote/SPY\" rel=\"noopener\" target=\"_blank\">(NYSE:</a><a class=\"ticker\" href=\"https://www.benzinga.com/quote/SPY\" target=\"_blank\">SPY</a>)<!-- --> — opened 0.8% lower on Friday, heading for a negative weekly close. </p><!--/$--><!--$--><p class=\"block core-block\">The Nasdaq 100 fell 1%, while the Dow Jones Industrial Average slipped 0.9%. </p><!--/$--><!--$--><p class=\"block core-block\">Shares of <strong>Nvidia Corp.</strong> <a class=\"ticker-link\" data-exchange=\"NASDAQ\" data-ticker=\"NVDA\" href=\"https://www.benzinga.com/quote/NVDA\" rel=\"noopener\" target=\"_blank\">(NASDAQ:</a><a class=\"ticker\" href=\"https://www.benzinga.com/quote/NVDA\" target=\"_blank\">NVDA</a>)<!-- --> sank nearly 2% after a 5.5% drop on Thursday, putting the stock on track for its worst two-day decline since April 2025.</p><!--/$--><!--$--><p class=\"block core-block\">Meanwhile, crude oil jumped 3.7% to around $67 per barrel, hovering near a seven-month-high, as rising tensions involving Iran injected fresh geopolitical risk into energy markets.</p><!--/$--><!--$--><p class=\"block core-block\">Gold gained 0.8% to $5,250 per ounce, extending its recent run of strength. Silver spiked 4.5% to $92. </p><!--/$--><!--$--><p class=\"block core-block\"><em>Image: Shutterstock</em></p><!--/$--><!--$--><div class=\"bz-optimizely-campaign bz-optimizely-campaign-bottom-50932619\" data-nosnippet=\"true\"></div><!--/$--></div></div>",
            "image": "https://www.benzinga.com/files/images/story/2026/02/27/Headquarters-Of-The-Federal-Reserve-In-W.jpeg",
            "link": "https://www.benzinga.com/news/politics/26/02/50932619/producer-inflation-january-market-reactions",
            "pub_date": "2026-02-27 23:56:26",
            "source": "benzinga",
            "kind": 1,
            "language": "en"
        }
    ]
}